Is a complete ALKS research report available?

No complete published report is available for Alkermes plc (ALKS) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Alkermes plc (ALKS)

NASDAQ: ALKS · USD

$45.2

+0.90 (+2.0%)· Recorded snapshot

Market cap	7.6B
Revenue (ttm)	1.7B
Net income (ttm)	66.1M
EPS (ttm)	$0.39
Shares out	167.8M
P/E (trailing)	116.5x
Volume	1,149,460
Beta	0.27

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 1.7B
Net income (ttm): 66.1M
EPS (ttm): $0.39
P/E (trailing): 116.5x
Market cap: 7.6B

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	ถือ

Metric	Value
Amount currency	USD
CIK code	0001520262
Company name	Alkermes plc
Country	Ireland
Country code	US
CUSIP number	G01767105
Earnings date	2026-11-03
Earnings time	bmo
Employees	2,050
Employees change	250
Employees growth	13.89%
Enterprise value	$8.5B
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	1987
In index	RUSSELL2000
Industry	Drug Manufacturers - Specialty & Generic
IPO date	1991-07-16
Is primary listing	Yes
Is SPAC	No
ISIN number	IE00B56GVS15
Last 10-K release date	2026-02-25
Last earnings date	2026-07-28
Last refreshed	2026-10-28
Last stock split date	2000-05-15
Last stock split type	Forward
Market cap	$7.6B
Market cap category	Mid-Cap
Next earnings date	2026-11-03
Options	Yes
Price	$45.22
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	ALKS
Website	https://www.alkermes.com

Metric

Value

Amount currency

USD

CIK code

0001520262

Company name

Alkermes plc

Country

Ireland

Country code

CUSIP number

G01767105

Earnings date

2026-11-03

Earnings time

bmo

Employees

2,050

Employees change

250

Employees growth

13.89%

Enterprise value

$8.5B

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

1987

In index

RUSSELL2000

Industry

Drug Manufacturers - Specialty & Generic

IPO date

1991-07-16

Is primary listing

Yes

Is SPAC

ISIN number

IE00B56GVS15

Last 10-K release date

2026-02-25

Last earnings date

2026-07-28

Last refreshed

2026-10-28

Last stock split date

2000-05-15

Last stock split type

Forward

Market cap

$7.6B

Market cap category

Mid-Cap

Next earnings date

2026-11-03

Options

Yes

Price

$45.22

Price currency

USD

Sector

Healthcare

SIC code

2834

Stock price date

2026-10-28

Symbol

ALKS

Website

https://www.alkermes.com

Metric	Value
Adjusted P/E ratio	20.44x
Average P/E ratio (3Y)	26.59x
Average P/E ratio (5Y)	28.43x
Earnings yield	0.86%
EV/Earnings	128.02x
EV/EBIT	37.91x
EV/EBITDA	29.71x
EV/FCF	38.19x
EV/Sales	5.08x
FCF / EV yield	2.62%
FCF yield	2.94%
Forward EV/Sales	4.51x
Forward P/S	4.02x
Graham number	9.71054
Graham upside	-78.42%
Industry forward P/E	13.86x
Industry P/E	173.47x
Lynch fair value	$1.94
Lynch upside	-95.69%
P/(FCF - SBC) ratio	73.12x
P/(OCF - SBC) ratio	56.86x
P/B ratio	4.11x
P/E ratio	116.47x
P/FCF ratio	34.06x
P/OCF ratio	30.06x
P/S ratio	4.53x
Price/EBITDA ratio	26.5x
Sector forward P/E	23.56x
Sector P/E	50.13x

Metric

Value

Adjusted P/E ratio

20.44x

Average P/E ratio (3Y)

26.59x

Average P/E ratio (5Y)

28.43x

Earnings yield

0.86%

EV/Earnings

128.02x

EV/EBIT

37.91x

EV/EBITDA

29.71x

EV/FCF

38.19x

EV/Sales

5.08x

FCF / EV yield

2.62%

FCF yield

2.94%

Forward EV/Sales

4.51x

Forward P/S

4.02x

Graham number

9.71054

Graham upside

-78.42%

Industry forward P/E

13.86x

Industry P/E

173.47x

Lynch fair value

$1.94

Lynch upside

-95.69%

P/(FCF - SBC) ratio

73.12x

P/(OCF - SBC) ratio

56.86x

P/B ratio

4.11x

P/E ratio

116.47x

P/FCF ratio

34.06x

P/OCF ratio

30.06x

P/S ratio

4.53x

Price/EBITDA ratio

26.5x

Sector forward P/E

23.56x

Sector P/E

50.13x

Metric	Value
EBIT margin	13.39%
EBITDA margin	17.09%
Effective tax rate	32.06%
FCF margin	13.29%
Gross margin	87.18%
Operating margin	13.39%
Pretax margin	5.84%
Profit margin	3.97%
Profit per employee	$32,255
Profitable quarters	1
Profitable years	3
Revenue per employee	$813,489
ROA	4.2%
ROA (5Y)	7.01%
ROCE	5.98%
ROE	3.85%
ROE (5Y)	18.55%
ROIC	5.47%
ROIC (5Y)	24.87%
SBC / revenue	7.1%
Tax / revenue	1.87%

Metric

Value

EBIT margin

13.39%

EBITDA margin

17.09%

Effective tax rate

32.06%

FCF margin

13.29%

Gross margin

87.18%

Operating margin

13.39%

Pretax margin

5.84%

Profit margin

3.97%

Profit per employee

$32,255

Profitable quarters

Profitable years

Revenue per employee

$813,489

ROA

4.2%

ROA (5Y)

7.01%

ROCE

5.98%

ROE

3.85%

ROE (5Y)

18.55%

ROIC

5.47%

ROIC (5Y)

24.87%

SBC / revenue

7.1%

Tax / revenue

1.87%

Metric	Value
EPS growth	-81.32%
EPS growth (Q)	-99.45%
EPS growth 3Y	-13.91%
EPS growth years	0
FCF growth	-53.81%
FCF growth (Q)	-0.11%
FCF growth 3Y	11.71%
FCF growth 5Y	20%
Gross profit growth	13.46%
Gross profit growth (Q)	25.7%
Gross profit growth 3Y	5.56%
Gross profit growth 5Y	9.59%
Net income growth	-81.02%
Net income growth (Q)	-99.43%
Net income growth 3Y	-13.73%
Net income growth years	0
OCF growth	-51.79%
OCF growth (Q)	-3.34%
OCF growth 3Y	8.61%
OCF growth 5Y	16.82%
Operating income growth	-40.33%
Operating income growth (Q)	-17.33%
Operating income growth 3Y	-11.78%
Revenue growth	10.79%
Revenue growth (Q)	26.97%
Revenue growth (QoQ)	26.24%
Revenue growth 10Y	9.59%
Revenue growth 3Y	4.48%
Revenue growth 5Y	8.68%
Revenue growth quarters	2
Revenue growth years	0

Metric

Value

EPS growth

-81.32%

EPS growth (Q)

-99.45%

EPS growth 3Y

-13.91%

EPS growth years

FCF growth

-53.81%

FCF growth (Q)

-0.11%

FCF growth 3Y

11.71%

FCF growth 5Y

20%

Gross profit growth

13.46%

Gross profit growth (Q)

25.7%

Gross profit growth 3Y

5.56%

Gross profit growth 5Y

9.59%

Net income growth

-81.02%

Net income growth (Q)

-99.43%

Net income growth 3Y

-13.73%

Net income growth years

OCF growth

-51.79%

OCF growth (Q)

-3.34%

OCF growth 3Y

8.61%

OCF growth 5Y

16.82%

Operating income growth

-40.33%

Operating income growth (Q)

-17.33%

Operating income growth 3Y

-11.78%

Revenue growth

10.79%

Revenue growth (Q)

26.97%

Revenue growth (QoQ)

26.24%

Revenue growth 10Y

9.59%

Revenue growth 3Y

4.48%

Revenue growth 5Y

8.68%

Revenue growth quarters

Revenue growth years

Metric	Value
Capital expenditures	$-29.5M
Depreciation and amortization	$61.6M
EBIT	$223.3M
EBITDA	$284.9M
EPS	$0.39
FCF per share	$1.32
Financing cash flow	$1.5B
Free cash flow	$221.7M
Free cash flow minus SBC	$103.2M
Gross profit	$1.5B
Income taxes	$31.2M
Investing cash flow	$-1.8B
Net borrowing	$1.5B
Net cash flow	$-9.7M
Net income	$66.1M
Operating cash flow minus SBC	$132.8M
Operating income	$223.3M
Revenue	$1.7B
Stock-based compensation	$118.4M

Metric

Value

Capital expenditures

$-29.5M

Depreciation and amortization

$61.6M

EBIT

$223.3M

EBITDA

$284.9M

EPS

$0.39

FCF per share

$1.32

Financing cash flow

$1.5B

Free cash flow

$221.7M

Free cash flow minus SBC

$103.2M

Gross profit

$1.5B

Income taxes

$31.2M

Investing cash flow

$-1.8B

Net borrowing

$1.5B

Net cash flow

$-9.7M

Net income

$66.1M

Operating cash flow minus SBC

$132.8M

Operating income

$223.3M

Revenue

$1.7B

Stock-based compensation

$118.4M

Metric	Value
Altman Z-Score	1.76
Book value per share	$10.79
Debt / EBITDA	5.28
Debt / equity	0.87
Debt / FCF	7.09
Goodwill	$594.3M
Interest coverage	3.78
Long-term assets	$2.9B
Long-term liabilities	$1.9B
Net cash (debt)	$-916M
Net cash / market cap	-12.13%
Net debt / EBITDA	3.21
Net debt / equity	0.51
Net debt / FCF	4.13
Piotroski F-Score	5
Property, plant and equipment	$294.4M
Shareholders' equity	$1.8B
Tangible book value	$-547.2M
Tangible book value per share	$-3.27
Total assets	$4.4B
Total cash	$656.6M
Total debt	$1.6B
Total liabilities	$2.6B
WACC	5.2%

Metric

Value

Altman Z-Score

1.76

Book value per share

$10.79

Debt / EBITDA

5.28

Debt / equity

0.87

Debt / FCF

7.09

Goodwill

$594.3M

Interest coverage

3.78

Long-term assets

$2.9B

Long-term liabilities

$1.9B

Net cash (debt)

$-916M

Net cash / market cap

-12.13%

Net debt / EBITDA

3.21

Net debt / equity

0.51

Net debt / FCF

4.13

Piotroski F-Score

Property, plant and equipment

$294.4M

Shareholders' equity

$1.8B

Tangible book value

$-547.2M

Tangible book value per share

$-3.27

Total assets

$4.4B

Total cash

$656.6M

Total debt

$1.6B

Total liabilities

$2.6B

WACC

5.2%

Metric	Value
Asset turnover	0.5
Current assets	$1.5B
Current liabilities	$662.1M
Current ratio	2.3
Inventory turnover	0.87
Net working capital	$238.2M
Quick ratio	1.68
Working capital	$860.8M
Working capital turnover	1.68

Metric

Value

Asset turnover

0.5

Current assets

$1.5B

Current liabilities

$662.1M

Current ratio

2.3

Inventory turnover

0.87

Net working capital

$238.2M

Quick ratio

1.68

Working capital

$860.8M

Working capital turnover

1.68

Metric	Value
Buyback yield / dilution	-0.22%
Dividend yield	0%
Shareholder yield	-0.22%

Metric

Value

Buyback yield / dilution

-0.22%

Dividend yield

Shareholder yield

-0.22%

Metric	Value
10Y price change	-12.57%
10Y return CAGR	-1.17%
10Y total return	-11.14%
150-day SMA	$43.33
15Y price change	156.35%
15Y return CAGR	6.59%
15Y total return	160.53%
1D price change	2.03%
1M price change	10.7%
1M total return	10.7%
1W price change	4%
1W total return	4%
1Y price change	52.15%
1Y return CAGR	52.2%
1Y total return	52.15%
20-day SMA	$42.08
200-day SMA	$40.32
20Y price change	158.7%
20Y return CAGR	4.95%
20Y total return	162.91%
3M price change	-14.24%
3M total return	-14.24%
3Y price change	89.21%
3Y return CAGR	24.35%
3Y total return	92.29%
50-day SMA	$44.21
50-day SMA vs 200-day SMA	50over200
52-week high	$55.67
52-week high date	2026-07-07
52-week low	$27.00
52-week low date	2026-03-19
5Y price change	57.84%
5Y return CAGR	9.91%
5Y total return	60.41%
6M price change	34.07%
6M total return	34.07%
All-time high	$98.50
All-time high date	2000-03-01
All-time low	$0.94
All-time low date	1994-12-19
Average true range (ATR)	$1.48
Average volume	2M
Beta (1Y)	0.19
Beta (2Y)	0.6
Beta (5Y)	0.27
Change from 52-week high	-18.77%
Change from 52-week low	67.48%
Change from all-time high	-54.09%
Change from all-time low	4,723.47%
Change from open	2.66%
Day's gap	-0.61%
Dollar volume	$52M
High price	$45.27
Low price	$44.05
Monthly RSI	60.38
Open price	$44.05
Position in 52-week range	95.9%
Premarket change	-0.02%
Premarket close	$44.32
Premarket price	$44.31
Previous close	$44.32
Price vs 150-day SMA	4.35%
Price vs 20-day SMA	7.46%
Price vs 200-day SMA	12.15%
Price vs 50-day SMA	2.29%
Relative volume	0.58
RSI	60.75
Sharpe ratio	1.14
Sharpe ratio (3Y)	0.64
Sharpe ratio (5Y)	0.29
Sortino ratio	2.06
Sortino ratio (3Y)	1.19
Sortino ratio (5Y)	0.61
Volume	1.1M
Weekly RSI	56.37
YTD price change	61.62%
YTD total return	61.62%

Metric

Value

10Y price change

-12.57%

10Y return CAGR

-1.17%

10Y total return

-11.14%

150-day SMA

$43.33

15Y price change

156.35%

15Y return CAGR

6.59%

15Y total return

160.53%

1D price change

2.03%

1M price change

10.7%

1M total return

10.7%

1W price change

1W total return

1Y price change

52.15%

1Y return CAGR

52.2%

1Y total return

52.15%

20-day SMA

$42.08

200-day SMA

$40.32

20Y price change

158.7%

20Y return CAGR

4.95%

20Y total return

162.91%

3M price change

-14.24%

3M total return

-14.24%

3Y price change

89.21%

3Y return CAGR

24.35%

3Y total return

92.29%

50-day SMA

$44.21

50-day SMA vs 200-day SMA

50over200

52-week high

$55.67

52-week high date

2026-07-07

52-week low

$27.00

52-week low date

2026-03-19

5Y price change

57.84%

5Y return CAGR

9.91%

5Y total return

60.41%

6M price change

34.07%

6M total return

34.07%

All-time high

$98.50

All-time high date

2000-03-01

All-time low

$0.94

All-time low date

1994-12-19

Average true range (ATR)

$1.48

Average volume

Beta (1Y)

0.19

Beta (2Y)

0.6

Beta (5Y)

0.27

Change from 52-week high

-18.77%

Change from 52-week low

67.48%

Change from all-time high

-54.09%

Change from all-time low

4,723.47%

Change from open

2.66%

Day's gap

-0.61%

Dollar volume

$52M

High price

$45.27

Low price

$44.05

Monthly RSI

60.38

Open price

$44.05

Position in 52-week range

95.9%

Premarket change

-0.02%

Premarket close

$44.32

Premarket price

$44.31

Previous close

$44.32

Price vs 150-day SMA

4.35%

Price vs 20-day SMA

7.46%

Price vs 200-day SMA

12.15%

Price vs 50-day SMA

2.29%

Relative volume

0.58

RSI

60.75

Sharpe ratio

1.14

Sharpe ratio (3Y)

0.64

Sharpe ratio (5Y)

0.29

Sortino ratio

2.06

Sortino ratio (3Y)

1.19

Sortino ratio (5Y)

0.61

Volume

1.1M

Weekly RSI

56.37

YTD price change

61.62%

YTD total return

61.62%

Metric	Value
Float	155.2M
Float percentage	92.51%
Shares change (QoQ)	4.38%
Shares change (YoY)	0.22%
Shares held by insiders	1.49%
Shares held by institutions	103.1%
Shares outstanding	167.8M
Short % of float	11.48%
Short % of shares	10.62%
Short ratio	8.2 days

Metric

Value

Float

155.2M

Float percentage

92.51%

Shares change (QoQ)

4.38%

Shares change (YoY)

0.22%

Shares held by insiders

1.49%

Shares held by institutions

103.1%

Shares outstanding

167.8M

Short % of float

11.48%

Short % of shares

10.62%

Short ratio

8.2 days

Alkermes plc (ALKS)

Price

Financial snapshot

Fair-value bridge

Latest news · ALKS

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ALKS indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on ALKS

Frequently asked questions